References on the Vaccine Safety

(1) Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b disease in the HiB vaccine era. JAMA 1993;269:221-6.

(2) Aho K, Konttinen A, Rajasalmi M, Wager O. Transient appearance of rheumatoid factor in connection with prophylactic vaccinations. Acta Pathol Microbial Scand 1962;56:478-9.

(3) Aho K, Somer T, Salo OP. Rheumatoid factor and immuno-conglutinin response following various vaccinations. PSEBM 1967;124:229-33.

(4) Al-Kassab AS, Raziuddin S. Abnormalities of CD4+ T Lymphocyte Proliferative Responses from Patients with Recently Diagnosed Insulin-dependant Diabetes Mellitus. Diabetes Research and Clinical Practice 1990;10:45-9.

(5) American Diabetes Association. Direct and indirect costs of diabetes in the United States in 1992. : American Diabetes Association, Alexandria, VA, 1993.

(6) Ammann AJ. T cell and T-B cell immunodeficiency disorders. Pediatric Clinics of North America 1977;24:293-311.

(7) Amsel SG, Hanukoglu A, Fried D, Wolyvovics M. Myocarditis after triple immunisation. Archives of Diseases in Childhood 1986;61:403-5.

(8) Andersson U, Bird AG, Britton S, Palacios R. Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunological Reviews 1981;57:5-38.

(9) Anonymous. Aphton Corporation, annual report.

(10) Arnqvist HJ, Littorin B, Nystrom L, et al. Difficulties in classifying diabetes at presentation in the young adult. Diabetic Medicine 1993;10:606-13.

(11) Ayvazian LF. Risk of repeated immunization. Annals of Internal Medicine 1975;82:589.

(12) Ayvazian LF, Badger TL. Disseminated lupus erythematous occuring among nursing students. NEJM 1948;239:565-70.

(13) Barbosa J, Bach FH. Cell-mediated autoimmunity in type I diabetes. Diabetes/Metabolism Reviews 1987;3:981-1004.

(14) Bart KJ, Orenstein WA, Hinman AR. The current status of immunization principles: recommendations for use of adverse reactions. J Allergy Cln Immunol 1987;79:296-315.

(15) Bernard NF, Ertug F, Margolese H. High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes 1992;41:40-6.

(16) Bijkerk H. Mass vaccination in the Netherlands. Symp Series Immunobiol Standard 1973;22:271-6.

(17) Biron P, Montpetit P, Infante-Rivard C, Lery L. Myasthenia gravis after general anethesia and hepatitis B vaccine. Arch Intern Medicine 1988;148:2685.

(18) Bodansky HJ, Dean BM, Grant PJ, et al. Does exposure to the rubella virus generate endocrine autoimmunity. Diabetic Medicine 1990;7:611-4.

(19) Brewster D. The epidemiology of Haemophilus influenzae invasive disease in Scotland prior to immunisation. Health Bull (Edinb) 1993;51:385-93.

(20) Britton DE, Houff SA, Eiben RM. Possible interactions between rabies vaccination and a progressive degenerative CNS disease. Archives of Neurology 1978;35:693.

(21) Brown RC, Blecher TE, French EA, Toghill PJ. Thrombotic thrombocytopenic purpura after influenza vaccination. BMJ 1973;May 5th:303.

(22) Burman P, Totterman TH, Oberg K, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leukocyte derived interferon. Journal of Clinical Endocrinology and Metabolism 1986;63:1086-90.

(23) Burnstein D, Mordes JP, Greiner DL, et al. Prevention of diabetes in BB/Wor Rat by single transfusion of spleen cells. Diabetes 1989;38:24-30.

(24) Caspary EA. Effect of live attenuated vaccines on the course of experimental allergic encephalitis. Eur Neurol 1977;16:176-80.

(25) Caspary EA, Field EJ, Ball J. Antibody studies in multiple sclerosis and experimental allergic encephalitis. Journal of Neurology, Neurosurgery and Psychiatry 1964;27:25-8.

(26) Chen RT, Glasser JW, Rhodes PH, et al. Vaccine safety datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics 1997;99:765-73.

(27) Classen DC, Classen JB. The timing of pediatric immunization and the risk of insulin-dependant diabetes mellitus. Infectious Diseases in Clinical Practice 1997;6:449-54.

(28) Classen JB. Method and composition for an early vaccine to protect against both infectious diseases and chronic immune mediated disorders or their sequela. PCT patent application 1994;PCT/US94/08825.

(29) Classen JB. The diabetes epidemic and the hepatitis B vaccine. New Zealand Medical Journal 1996a;109:366.

(30) Classen JB. Diabetes epidemic follows hepatitis B immunization program. New Zealand Medical Journal 1996b;109:195.

(31) Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity 1996c;24:137-45.

(32) Classen JB. Cyclosporine induced autoimmunity in newborns prevented by early immunization. Autoimmunity 1997;in press.

(33) Classen JB, Classen DC. Vaccines modulate type I diabetes. Diabetologia 1996;39:500-1.

(34) Classen JB, Classen DC. Incidence of IDDM in Germany is not higher than predicted. Diabetes Care 1997;20:1799-800.

(35) Classen JB, Shevach EM. Evidence that cyclosporine treatment during pregnancy predisposes offspring to develop autoantibodies. Transplantation 1991;51:1052-7.

(36) Classen JB, Shevach EM. Post-thymectomy organ-specific autoimmunity: enhancement by cyclosporine A and inhibition by IL-2. Autoimmunity 1993;15:55-9.

(37) Colling RG, Pearson TC, Brown JC. Association of bacterial carbohydrate-specific cold agglutin antibody production with immunization by group c, group b type III, and streptococcus pneumonia type XIV streptococcal vaccines. Infection and Immunity 1983;41:205-13.

(38) Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990;65:2237-42.

(39) Crisa L, Mordes JP, Rossini AA. Autoimmune diabetes mellitus in the BB rat. Diabetes/Metabolism Reviews 1992;8:9-37.

(40) Dahlquist G. Etiological aspects of insulin-dependant diabetes mellitus: an epidemiological perspective. Autoimmunity 1993;15:61-5.

(41) Dahlquist G, Frisk G, Svanberg L, Forsgren L, Didherolom H. Indications that maternal Coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 1995;38:1371-3.

(42) Dahlquist G, Kallen B. Maternal-child blood group incompatibility and other perinatal events increase the risk for early -onset Type 1 (Insulin-dependant) diabetes mellitus. Diabetologia 1992;35:671-5.

(43) Dokheel TM. An epidemic of childhood diabetes in the United States. Diabetes Care 1993;16:1606-11.

(44) Drykoningen CEM, Mulder ALM, Vaandrager GJ, LaPorte RE, Bruining GJ. The incidence of male childhood type 1 (insulin-dependent) diabetes mellitus is rising rapidly in the Netherlands. Diabetologia 1992;35:139-42.

(45) Elias D, Markovitis D, Reshef T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. ProcNatlAcadSciUSA 1990;87:1576-80.

(46) Engleman EG, Sonnenfield G, Dauphinee M, et al. Treatment of NZB/NZW f1 hybrid mice with Mycobacterium bovis strain of BCG or type II interferon preparations acclerates autoimmune disease. Arthritis and Rheumatism 1981;24:1396-402.

(47) Eskola J, Kayhty H, Takala AK, et al. A randomized, prospective field trial of a conjugated vaccine in the protection of infants and young children against invasive Haemophilus influenza type b disease. NEJM 1990;323:1381-7.

(48) Espmark JA, Rabo E, Heller L. Smallpox vaccination before the age of three months: evaluation of safety. Symp Series Immunobiol Standard 1972;19:243-8.

(49) Fescharek R, Quast U, Maass G, Merkle W, Schwarz S. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II Tolerability and analysis of spontaneously reported side effects. Vaccine 1990;8:446-56.

(50) Fischer GW, Ottolini M, Mond JJ. Prospects for vaccines during pregnancy and in the newborn period. Clinics in Perinatology 1997;24:231-49.

(51) Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 1991;129:1382-90.

(52) Flier JS, Underhill LH. Type I diabetes mellitus a chronic autoimmune disease. NEJM 1986;314:1360-8.

(53) Formby B, Jacobs C, Dubuc P, Shao T. Exogenous administration of IL-1 alpha inhibits active and adoptive transfer autoimmune diabetes in mice. Autoimmunity 1992;12:21-7.

(54) Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 Immunity in Neonatal Mice. Science 1996;271:1728-30.

(55) Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. JExpMed 1992;175:1409-12.

(56) Gardner S, Bingley PJ, Sawtell PA, Weeks S, Gale EA. Rising incidence of insulin dependent diabetes in children under 5 years in Oxford region: time trend analysis. BMJ 1997;315:713-6.

(57) Gaskins HR, Prochazka M, Hamaguchi K, Serreze DV, Leiter EH. Beta cell expression of endogenous xenotrophic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice. JClinInvest 1992;90:2220-7.

(58) Gearing AJH, Bird C, Wadha M, Redhead K. The primary and secondary cellular immune responses to whole cell Bordetella pertussis vaccine and its components. ClinExpImmunol 1987;68:275-81.

(59) Gerfo PL, Feind C, Weber C, Ting W. Immunotherapy of cancer by the induction of autoimmunity. Surgery 1983;94:959-65.

(60) Ginspberg-Fellner F, Witt ME, Yagihashi S, et al. Congenital rubella syndrome as a model for type 1 (insulin dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 1984;27:87-9.

(61) Giudice GD, Gervaix A, Costantino P, et al. Priming to heat shock proteins in infants vaccinated against pertussis. Journal of Immunology 1993;150:2025-32.

(62) Greenberg L, Fleming DS. Increased efficiency of diptheria toxoid when combined with the pertussis vaccine. Canadian Journal of Public Health 1947;38:279-82.

(63) Greiner DL, Mordes JP, Handler ES, Angelillo M, Nakamura N, Rossini AA. Depletion of RT6.1 positive lymphocytes induces diabetes in resistant Biobreeding/Worchester (BB/W) rats. JExpMed 1987;166:461-75.

(64) Griffin PD. Immunization against HCG. Human Reproduction 1994;9:267-72.

(65) Griffith AH. Achievements in Europe. Symp Series Immunobiol Standard 1973;22:13-24.

(66) Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986;35:237-41.

(67) Hackett E, Beech M. Transient appearance of autoimmune antibodies during prophylactic immunization. Journal of Immunology 1960;85:533-8.

(68) Halsey N, Galazka A. The effect of DTP and oral poliomyelitis immunization schedules initiated at birth to 12 weeks of age. Bulletin of the World Health Organization 1985;63:1151-69.

(69) Haneberg B, Matre R, Winsnes R, Dalen A, Vogt H, Finne PH. Acute hemolytic anemia related to diphtheria-pertussis-tetanus vaccination. Acta Paediatrica Scandanavia 1978;67:345-50.

(70) Hatamori N, Yokono K, Nagata M, et al. Suppresser T-cell abnormality in NOD mice before onset of diabetes. Diabetes Research and Clinical Practice 1989;6:265-70.

(71) Hawkins T, Gala R, Dunbar JC. The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. PSEBM 1993;202:201-5.

(72) Hayward AR. Development of lymphocyte responses and interactions in the human fetus and newborn. Immunological Reviews 1981;57:39-60.

(73) Heijbel H, Chen RT, Dahlquist G. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care 1997;20:173-5.

(74) Helle EPJ, Koskenvuo K, Heikkila J, Pikkarainen J, Weckstrom P. Myocardial complications of immunisation. Annals of Clinical Research 1978;10:280-7.

(75) Hemachuda T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P. Myelin basic protein as an encephalomyelitis and polyneuritis following rabies vaccination. NEJM 1987;316:369-74.

(76) Herroelen L, De Keyser J, Ebinger G. Central-nervous system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 1991;338:1174.

(77) Hjorth RN, Bonde GM, Piner E, Hartzell RW, Rorke LB, Rubin BA. Experimental neuritis induced by a mixture of neural antigens and influenza vaccines. Journal of Neuroimmunology 1984;6:1-8.

(78) Huang X, Yuan J, Goddard A, et al. Interferon expression in pancreases of patients with type I diabetes. Diabetes 1995;44:658-64.

(79) Huang YP, Gauthey L, Michel M, et al. The relationship between vaccine-induced antibody responses and vaccine induced nonspecific autoantibody responses in healthy older women. Journal of Gerontology 1992;47:m50-5.

(80) Hulme MJ, Fehilly CB, Hearn JP. The immune response to hCG-beta subunit in rats and the effects of active immunization on their fertility. J Reproductive Immunology 1980;1:329-36.

(81) Hyoty H, Hiltunen M, Knip M, et al. A prospective study on the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995;44:652-7.

(82) Hyoty H, Hiltunen M, Reunanen A, et al. Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Diabetologia 1993;36:1303-8.

(83) Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. ProcNatlAcadSciUSA 1990;87:968-72.

(84) Jaworski MA, Jewell L, Honore L. Induction of diabetes mellitus in diabetes resistant lines of BB rats. Diabetes 1985;34 Suppl 1:72A.

(85) Katsh S. Adjuvants and aspermatogenesis in guinea pigs. Int Arch Allergy 1964;24:319-31.

(86) Kawakami Y, Kuzuya N, Watanabe T, Uchiyama Y, Yamashita K. Induction of experimental thyroiditis in mice by recombinant interferon gamma administration. Acta Endocrinologica 1990;122:41-8.

(87) Kelton JG. Vaccination-associated relapse in immune thrombocytopenia. JAMA 1981;245:369-71.

(88) Kemp T, Pearce N, Fitzharris P, et al. Is infant immunization a risk factor for childhood asthma or allergy. Epidemiology 1997;8:678-80.

(89) Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Advances in Immunology 1992;51:285-323.

(90) King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance. Diabetes Care 1993;16:157-77.

(91) Klemparskaya N. Autohaemolysis-producing cells in mice injected with bacterial vaccines. Immunology 1973;25:11-5.

(92) Knospe S, Kohler E, Rjasanowski I, Titze K. Autologous mixed lymphocyte reaction in newly diagnosed type-1 diabetes. Exp Cln Endocrinology 1990;95:148-56.

(93) Kojima A, Prehn RT. Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 1981;14:15-27.

(94) Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Laboratory Investigation 1976;34:550-7.

(95) Kolb H. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes/Metabolism Reviews 1987;3:751-78.

(96) Kolb H. Benign versus destructive insulitis. Diabetes/Metabolism Reviews 1997;13:139-46.

(97) Kolb H, Zielasek J, Treichel U, Freytag G, Wrann M, Kiesel U. Recombinant interleukin 2 enhances spontaneous insulin dependent diabetes in BB rats. European Journal of Immunology 1986;16:209-12.

(98) Kurikka S, Kayhty H, Peltola H, Saarinen L, Eskola J, Makela H. Neonatal immunization: response to Haemophilus influenza Type b-tetanus toxoid conjugate vaccine. Pediatrics 1995;95:815-22.

(99) Landin-Olsson M, Karlsson A, Dahlquist G, et al. Islet cell and other organ-specific autoantibodies in all children developing Type 1 (Insulin-dependant) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989a;32:387-95.

(100) Landin-Olsson M, Karlsson A, Dahlquist G, et al. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in sweden during one year and in matched control children. Diabetologia 1989b;32:387-95.

(101) Lee MS, Herrath M, Reiser H, Oldstone MA, Sarvetnick N. Sensitization to self (virus) antigen by in situ expression of murine interferon gamma. JClinInvest 1995;95:486-92.

(102) Levine S, Sowinski R. The role of the adrenal in relapses of experimental allergic encephalomyelitis. PSEBM 1975;149:1032-5.

(103) Levine S, Wenk EJ. Exacerbation and transformation of allergic encephalomyelitis by the pertussis vaccine. PSEBM 1966;112:115-8.

(104) Levine S, Wenk EJ. Hyperacute allergic encephalomyelitis, lymphatic system as site of adjuvant effect of pertussis vaccine. American Journal of Pathology 1967;50:465-81.

(105) Lewis K, Jordan SC, Cherry JD, Sakai RS, Le CT. Petechiae and urticaria after DTP vaccination, detection of circulating immune complexes containing vaccine-specific antigens. J Pediatrics 1986;109:1009-12.

(106) Lipnick RN, Karsh J, Stahl NI, Blackwelder WC, Schiffman G, Klippel JH. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. Journal of Rheumatology 1985;12:1118-21.

(107) Lorini R, De Amici M, Cortona L. Spontaneous and pokeweed mitogen-induced in Vitro IgM production in children and adolescents with insulin-dependant diabetes mellitus. Hormone Research 1989;32:208-12.

(108) Louie JS, Nies KM, Shoji KT, et al. Clinical and antibody response after influenza immunization in systemic lupus erythematous. Annals of Internal Medicine 1978;88:790-2.

(109) Maclaren N. Immunology of diabetes mellitus. Annals of Allergy 1992;68:5-9.

(110) Mancini RE. Allergic aspermatogeneisis experimentally induced in men and animals. In: Thomas L, Uhr JW, Grant L, eds. International Symposium on Injury, Inflammation and Immunity. England: Stoke Pages, 1962:365-87.

(111) Mannhalter JW, Neychev HO, Zlabinger GJ, Ahmad R, Eibl MM. Modulation of the human immune response by non-toxic and non-pyrogenic adjuvant aluminum hydroxide: effect on antigen uptake and antigen presentation. ClinExpImmunol 1985;61:143-51.

(112) Marks JB, Skyler JS. Immunotherapy of type I diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1991;72:3-9.

(113) Martin S, Schernthaner G, Nerup J, et al. Follow-up of cyclosporin A treatment in type 1 (insulin dependent) diabetes mellitus: lack of long-term effects. Diabetologia 1991;34:429-34.

(114) Meiselas LE, Zingale SB, Lee SL, Richman S, Siegel M. Antibody production in rheumatic diseases, the effect of Brucella antigen. JClinInvest 1961;40:1872-81.

(115) Miller H, Cendrowski W, Schapira K. Multiple sclerosis and vaccination. BMJ 1967;22:210-3.

(116) Moodie AS, Cheng GKK. Concurrent BCG and smallpox vaccination in newborn babies. Tubercle, London 1962;43:155-60.

(117) Mordes JP, Desemone J, Rossini AA. The BB rat. Diabetes/Metabolism Reviews 1987;3:725-50.

(118) Newton N, Janati A. Guillain-Barre syndrome after vaccination with purified tetanus toxoid. Southern Medical Journal 1987;80:1053-4.

(119) Niskanen L, Karjalainen J, Sarlund H, Sittonen O, Uusitupa M. Five-year follow-up of islet cell antibodies in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991;34:402-8.

(120) Numazaki K, Goldman HY, Wong I, Wainberg MA. Infection of cultured human fetal pancreatic cells by rubella virus. American Journal of Clinical Pathology 1989;91:446-51.

(121) Odent MR, Culpin EE, Kimmel T. Pertussis vaccination and asthma: is there a link? JAMA 1994;272:592-3.

(122) Onica D, Mihalcu F, Lenkel R, Gherman M, Tudor M. Autoantibodies detected in rabbits hyperimmunized with group A,C, and G streptococcal vaccines. Infection and Immunity 1977;18:624-8.

(123) Paffy G, Merei FT. The possible role of vaccines and sera in the pathogenesis of multiple sclerosis. World Neurology 1961;2:167-71.

(124) Palit J, Chattopadhyay C, Malaviya AN, Uberoi S, Kumar R. Some immunological parameters in rheumatoid arthritis from India. Biomedicine 1977;27:70-3.

(125) Panitch HS, Haley AS, Hirsch RL, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987;April 18:893-4.

(126) Parfrey NA, Prud’homme GJ, Colle E, Fuks A, Seemayer TA, Guttmann RD. Immunologic and genetic studies of diabetes in the BB rat. Critical Reviews in Immunology 1989;9:45-65.

(127) Paterson PY. Adjuvants, cell-mediated immune responses and autoimmune diseases. Journal of the Reticuloendothelial Society 1973;1973:426-40.

(128) Peeler RN, Kadul PJ, Cluff LE. Intensive immunization of man, evaluation of possible adverse events. Annals of Internal Medicine 1965;63:44-57.

(129) Polak MF. Complications of smallpox vaccination in the Netherlands, 1959-1970. Symp Series Immunobiol Standard 1972;19:235-42.

(130) Pontesilli O, Carotenuto P, Gazda LS, Pratt PF, Prowse SJ. Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study. ClinExpImmunol 1987;70:84-93.

(131) Poser CM, Behan PO. Late onset of Guillain-Barre syndrome. Journal of Neuroimmunology 1982;3:27-41.

(132) Pozzilli P, Pagani S, Arduini P, et al. In Vivo determination of cell mediated immune responses in diabetic patients using a multiple intradermal antigen dispenser. Diabetes Research 1987;6:5-8.

(133) Rabin J. Hazards of influenza vaccine in neurologic patients. JAMA 1973;225:63-4.

(134) Ramiya VK, Lan MS, Wasserfall CH, Notkins AL, Maclaren NK. Immunization therapies in the prevention of diabetes. Journal of Autoimmunity 1997;10:287-92.

(135) Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996;271:1723-6.

(136) Ries K, Shemonsky NK. Acute lupus erythematous (SLE) following polyvalent pneumococcal vaccine. South Dakota Medical Journal 1981;24(3):27-8.

(137) Ristow SC, Douglas RG, Condemi JJ. Influenza vaccination of patients with systemic lupus erythematosus. Annals of Internal Medicine 1978;88:786-9.

(138) Roath S. Hemolytic disease and thymic function. NEJM 1974;291:420.

(139) Rocken M, Urban JF, Shevach EM. Infection breaks T-cell tolerence. Nature 1992;359:79-82.

(140) Roden AT. . Proceedings of the Royal Scociety of Medicine 1974;67:24.

(141) Rose NR, Herskowitz A, Neumann DA, Neu N. Autoimmune myocarditis. Immunology Today 1988;9:117-20.

(142) Rose NR, Twarog FJ, Crowle AJ. Murine thyroiditis importance of adjuvant and mouse strain for the induction of thyroid lesions. Journal of Immunology 1971;106:698-704.

(143) Rossini AA, Handler ES, Greiner DL, Mordes JP. Insulin dependent diabetes mellitus hypothesis of autoimmunity. Autoimmunity 1991;8:221-35.

(144) Rudofsky UH. Studies on the pathpgenesis of experimental autoimmune renal tubulinterstial disease in guinea-pigs. ClinExpImmunol 1976;25:455-61.

(145) Ryniewicz B, Badurska B. Follow-up study of myastenic children after thymectomy. Journal of Neurology 1977;217:133-8.

(146) Sakaguchi S, Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. Journal of Immunology 1989;142:471-80.

(147) Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. JExpMed 1982;156:1577-86.

(148) Sarzotti M, Robbins DS, Hoffman PM. Induction of protective CTL responses in Newborn mice by a murine retrovirus. Science 1996;271:1726-8.

(149) Satoh J, Seino H, Shintani S, et al. Inhibition of Type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha. Journal of Immunology 1990;145:1395-9.

(150) Schattner A, Ben-Chetrit E, Schmilovitz H. Poliovaccines and the course of systemic lupus erythematous, a retrospective study in 73 patients. Vaccine 1992;10:98-100.

(151) Schutze MP, LeClerc C, Jolivet M, et al. A potential anti-pregnancy vaccine built by conjugation of the B-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide. American Journal of Reproductive Immunology 1987;14:84-90.

(152) Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA. Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer 1991;68:2384-90.

(153) Serreze DV, Hamaguchi K, Leiter EH. Immunostimulation circumvents diabetes in NOD/Lt mice. Journal of Autoimmunity 1989;2:759-76.

(154) Shamis I, Gordon O, Albag Y, Goldsand G, Laron Z. Ethnic differences in the incidence of childhood IDDM in Israel (1965-1993). Diabetes Care 1997;20:504-8.

(155) Shapiro ED, Murphy TV, Wald ER, Brady CA. The protective efficacy of Haemophilus b polysaccharide vaccine. JAMA 1988;260:1419-22.

(156) Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-9.

(157) Shulman S, Yantorno C, Bronson P. Cryo-Immunology, a method of immunization to autologous tissue. PSEBM 1967;124:658-61.

(158) Silverman DA, Rose NR. Neonatal thymectomy increases the incidence of spontaneous and methylcholanthrene-enhanced thyroiditis in rats. Science 1974;184:162-3.

(159) Sinaniotis CA, Daskalopoulou E, Lapatsanis P, Doxiadis S. Diabetes mellitus after mumps vaccination. Archives of Diseases in Childhood 1975;50:749.

(160) Singh B, Rabinovitch A. Influence of microbial agents on the development and prevention of autoimmune diabetes. Autoimmunity 1993;15:209-13.

(161) Skinner R, Christie P, Cowden JM. The measles/rubella immunisation campaign in Scotland. Health Bull (Edinb) 1996;54:88-98.

(162) Soanes WA, Ablin RJ, Gonder MJ. Remmission of metastatic lessions following cryosurgery in prostatic cancer: immunologic considerations. Journal of Urology 1970;104:154-9.

(163) Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type I. NEJM 1996;334:1222-30.

(164) Stewart SR, Gershwin ME. The associations and relationships of congenital immune deficiency states and autoimmune phenomena. Seminars in Arthritis and Rheumatism 1979;9:98-123.

(165) Suenaga K, Yoon JW. Association of beta-cell-specific expression of endogenous retrovirus with development of insulitis and diabetes in NOD mouse. Diabetes 1988;37:1722-6.

(166) Surcel HM, Karttunen R, Ilonen J, Kaar ML. Lymphocyte responsiveness and interleukin 2 production in type 1 (Insulin-dependant) diabetes mellitus. J Cln Lab Immunol 1987;22:163-4.

(167) Sutjita M, Hohmann A, Comacchio R, Bradley J. Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids. ClinExpImmunol 1988;73:191-7.

(168) Takasu N, Komiya I, Nagasawa Y, Asawa T, Yamada T. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing’s syndrome due to an adrenocortical adenoma. NEJM 1960;1990:1708-12.

(169) Taylor B, Norman AP, Orgel HA, Stokes CR, Turner MW, Soothill JF. Transient IgA deficiency and pathogenesis of infantile atopy. Lancet 1973;July 21:111-3.

(170) Tecson F, Bornstein B. Influenza immunization and lupus erythematous. Annals of Internal Medicine 1978;89:574.

(171) Temple RC, Luzio SD, Schneider AE, et al. Insulin deficiency in non-insulin-dependent diabetes. Lancet 1989;February 11:293-5.

(172) Tonooka N, Leslie GA, Greer MA, Olson JC. Lymphoid thyroiditis following immunization with group A streptococcal vaccine. American Journal of Pathology 1978;92:681-90.

(173) Toro G, Vergara I, Roman G. Neuroparalytic accidents of antirabies vaccination with suckling mouse brain vaccine. Archives of Neurology 1977;34:694-700.

(174) Trucco M, Dorman JS. Immunogenetics of insulin-dependant diabetes mellitus in humans. Critical Reviews in Immunology 1989;9:201-45.

(175) Tudela P, Marti S, Bonal J. Systemic lupus erythematous and vaccination against hepatitis B. Nephron 1992;62:236.

(176) Tuomilehto J, Virtala E, Karvonen M, et al. Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. International Journal of Epidemiology 1995;24:984-92.

(177) Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 1997;350:1288-93.

(178) Tvede N, Heilmann C, Christensen D. Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides. ClinExpImmunol 1989;76:404-11.

(179) Twarog FJ, Kenney E, Rose NR. Adjuvants for the production of autoimmune thyroiditis in rats. PSEBM 1970;133:185-9.

(180) Twarog FJ, Rose NR. The adjuvant effect of pertussis vaccine in experimental thyroiditis of the rat. PSEBM 1969;1969:434-9.

(181) Varey AM, Dean BM, Walker DR, Bone AJ, Baird JD, Cooke A. Immunological responses of the BB rat colony in Edinburgh. Immunology 1987;60:131-4.

(182) Vautier G, Carty JE. Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. British J Rheumatology 1994;33:991-8.

(183) Verheul HAM, Schot LPC, Schuurs AHWM. Effects of sex, gonadectomy and several sex steroids on the development of insulin-dependant diabetes mellitus in the BB rat. ClinExpImmunol 1986;63:656-62.

(184) Welch MJ, Fong S, Vaughan J, Carson D. Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. ClinExpImmunol 1982;51:299-304.

(185) Whaley K, Macsween RNM. Experimental induction of immune sialadenitis in guinea-pigs using different adjuvants. ClinExpImmunol 1974;17:681-4.

(186) White CS, Adler WH, McGann VG. Repeated immunization: possible adverse effects. Annals of Internal Medicine 1974;81:594-600.

(187) Williams GW, Steinberg AD, Reinerstein JL, Klassen LW, Decker JL, Dolin R. Influenza immunization in systemic lupus erythematous. Annals of Internal Medicine 1978;88:729-34.

(188) Wilson CA, Jacobs C, Baker P, et al. IL-1beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB Rat. Journal of Immunology 1990;144:3784-8.

(189) Wrench J, McWhirter M, Pearson S. . BMJ 1991;302:787-8.

(190) Zielasek J, Jackson RA, Eisenbarth GS. The potentially simple mathematics of type I diabetes. Clinical Immunology and Immunopathology 1989;52:347-65.

(191) Zilber N, Simchen E, Wartski S, Marcus JH, Shakya GR. Effect of mass BCG vaccination at birth on the incidence of tuberculosis among Jewish children in Israel. Israel Journal of Medical Sciences 1984;20:1150-7.

(192) Zupanska B, Lawkowicz W, Gorska B, et al. Autoimmune haemolytic anemia in children. British Journal of Haematology 1976;34:511-20.

 

Supported  by
CLINIC FOR CHILDREN

Yudhasmara Foundation

JL Taman Bendungan Asahan 5 Jakarta Indonesia 102010

phone : 62(021) 70081995 – 5703646

http://childrenclinic.wordpress.com/

 

 

Clinical and Editor in Chief :

DR WIDODO JUDARWANTO

email : judarwanto@gmail.com

 

 

 

 

 

 

 

Copyright © 2009, Clinic For Children Information Education Network. All rights reserved.

 

Iklan

One response to “References on the Vaccine Safety

Tinggalkan Balasan

Isikan data di bawah atau klik salah satu ikon untuk log in:

Logo WordPress.com

You are commenting using your WordPress.com account. Logout / Ubah )

Gambar Twitter

You are commenting using your Twitter account. Logout / Ubah )

Foto Facebook

You are commenting using your Facebook account. Logout / Ubah )

Foto Google+

You are commenting using your Google+ account. Logout / Ubah )

Connecting to %s